Boston Sci defends defective mesh claims

·1-min read

Pelvic device maker Boston Scientific is standing by the safety and quality of its products amid two class actions alleging women weren't properly warned the implants were defective.

AJB Stevens and Shine Lawyers have launched cases this month in the NSW Supreme Court and Federal Court respectively accusing the US-based medical device company of being negligent about the risks of severe complications.

The part-plastic implants were used to fix or reduce the severity of pelvic organ prolapse or stress urinary incontinence between 2004 and 2018.

But instead, the law firms allege the devices caused chronic pain, organ damage, new incontinence issues and other complications.

Boston Scientific on Tuesday said it intends to "vigorously defend itself" against the claims.

"As always, patient safety is our highest priority and we stand by the safety and quality of our products," the company said in a statement to AAP.

"Our devices meet rigorous internal safety standards, international standards, as well the standards of regulatory bodies across the globe."

Another pelvic mesh maker, Johnson & Johnson, faces a potential payout in excess of $100 million after the Federal Court in 2019 found it breached its duty of care to women implanted with its devices.

More than 10,000 people had joined that class action by March 5, when Johnson & Johnson's appeal against the 2019 ruling was dismissed.